Polydex Pharmaceuticals Story Overview

POLXF -- USA Stock  

USD 0.82  0.0015  0.18%

Macroaxis News
  
By David Taylor

The industry average is where I look to next to determine where this stock should be in relation to they earnings potential.  This company is trading at 6.83 times earnings.  The industry and sector averages, respectively, are trading at 64.14 times and 63.11 times earnings.  This stock is trading at 1/10th the industry average despite positive earnings and increasing earnings growth.  

Given the EPS ratio, if the company were to be trading at .5 the industry average, 30-times EPS, the stock would be trading at $15.00 per share, a nearly 1,000 percent return.  Keep in mind that only gets the stock up to half the industry average.  

Polydex Pharma is trading at 110 the industry average offering a huge bargain with positive earnings

Polydex Pharma is trading at 1/10 the industry average offering a huge bargain with positive earnings.  Over the past many years earnings have been positive and increasing.  And, yet, the stock is trading at a single-digit EPS ratio.  Whereas the industry average is 65-times earnings, this pharmaceutical company is trading at 6-times earnings.  This is a tremendous opportunity.  




Polydex Pharmaceuticals is mostly a veterinary pharmaceutical company.  The develop, manufacture and distribute their products worldwide.  They are a smaller company with a market capitalization of only $6.2 million.  Their share price is $1.70 per share.  

The pet industry is a $15 billion per year sector.  Of that, there is a large percentage that goes towards health care from either veterinary visits and treatments.  Americans, and more increasingly the rest of the world, spend a considerable amount of money on their pets.  

Earnings-per-share gives a strong indication of what a company will be earning in the future, although this is not a certainty; it is only an indication.  If earnings-per-share are increasing over a given period, say five years, then the indication is that the company will continue to increase their earnings in the next year.  

In the case of POLXF, their earnings have been increasing over the latest few years, as this listing shows:

2012:  -$0.13  

2013:   $0.22  

2014:   $0.20  

2015:   $0.50 

The first thing you might see is that earnings for the previously complete year are on $0.50 in 2015.  Earnings are slated to rise above that for 2016.  But, how much does it cost to “earn” that next year’s earnings?  As mentioned above, only $1.70 per share.  Given all the variables, if the share price remained exactly the same while simultaneously the earnings remained the same, you would “earn” 29% for the year.  I am having a difficult time locating a better return on an annual basis than that.  That is an astronomically high earnings ratio.  

The industry average is where I look to next to determine where this stock should be in relation to they earnings potential.  POLXF is trading at 6.83 times earnings.  The industry and sector averages, respectively, are trading at 64.14 times and 63.11 times earnings.  This stock is trading at 1/10th the industry average despite positive earnings and increasing earnings growth.  

Given the EPS ratio, if the company were to be trading at 1/2 the industry average, 30-times EPS, the stock would be trading at $15.00 per share, a nearly 1,000 percent return.  Keep in mind that only gets the stock up to half the industry average.  

Another key variable that I find compelling about this company is its Inventory Turnover Ratio.  It leads the industry 3.79 versus 2.70.  It sells more of its inventory at a higher pace and a higher margin ratio.  This shows how effective management is at its job of returning value to investors.  And, yet, the stock is priced so low.  

Another point I wanted to show was the gross profit margin versus the industry.  POLXF earns slightly more than double the industry average, 22.8 percent versus 11.5 percent, respectively.  The company not only sells its inventory at a faster rate it also earns more in margins per sale.  

The economy itself is expanding throughout the world.  This will give POLXF the opportunity to expand its sales and continue to grow as a company.  The overall stock market is trading at 25 times earnings on average.  At some point, investors are going to start looking for increased value from earnings potential.  A company like POLXF is exactly that opportunity.  There is so much potential value in a stock priced so discounted to the industry and its own earnings.  

There are very few bargains in the market at this point. However, POLXF is far more than a bargain.  This is a bargain that is beyond difficult to pass.  Add this stock to your portfolio and hold this for a very long period.  You will be glad you did.  

Story Momentum

This story impact on price volatility cannot be determined at this time. Please check this story after some time to allow current data to be analyzed.

Similar stores for Polydex Pharmaceuticals

over a week ago at http://bharatapress.com 
Monument Capital Management Lifted Holding in FedEx Co. - BharataPress
news
Monument Capital Management Lifted Holding in FedEx Co. BharataPressMonument Capital Management lifted its position in FedEx Co. by 12.4 percent during the 3rd quarter, according to its most recent disclosure with the ...
over two weeks ago at http://bharatapress.com 
Quanta Services Target Price Lowered to 50.00 at Citigroup - BharataPress
news
Quanta Services Target Price Lowered to 50.00 at Citigroup BharataPressQuanta Services had its price target cut by equities researchers at Citigroup from 53.00 to 50.00 in a research note issued on Friday, November ...
over two weeks ago at http://www.fairfieldcurrent.com 
Head-To-Head Comparison Polydex Pharmaceuticals LSB Industries - Fairfield Current
news
Head-To-Head Comparison Polydex Pharmaceuticals LSB Industries Fairfield CurrentPolydex Pharmaceuticals and LSB Industries are both small-cap medical companies, but which is the better business We will ...
over three weeks ago at http://bharatapress.com 
Alphabet Inc Shares Bought by State Treasurer State of Michigan - BharataPress
news
Alphabet Inc Shares Bought by State Treasurer State of Michigan BharataPressState Treasurer State of Michigan increased its position in Alphabet Inc by 0.3 percent in the second quarter, HoldingsChannel reports. The firm ...
over a month ago at http://simplywall.st 
Is Lannett Company Incs Growth Strong Enough To Justify Its November Share Price - Simply Wall St
news
Is Lannett Company Incs Growth Strong Enough To Justify Its November Share Price Simply Wall StLannett Company Inc is considered a high growth stock. However its last closing price of 4.13 left investors wondering whether this growth has ...
over a month ago at www.macroaxis.com 
Purchase by George Usher of 3000 shares of Polydex Pharmaceuticals
Macroaxis News
Filed transaction by Polydex Pharmaceuticals L director. General open market or private purchase of non-derivative or derivative security
over two months ago at www.macroaxis.com 
Exercise or conversion by Seidler John L E of 3650 shares of Polydex Pharmaceuticals subject to Rule 16b-3
Macroaxis News
Filed transaction by Polydex Pharmaceuticals L director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
over two months ago at http://www.nasdaq.com 
Polydex Reports Second Quarter Financial Results
nasdaq News
NasdaqFull coverage
over three months ago at www.macroaxis.com 
Acquisition or disposition of Polydex Pharmaceuticals securities by Seidler John L E
Macroaxis News
Filed transaction by Polydex Pharmaceuticals L director. Acquisition or disposition under rule 16b-3
over three months ago at http://www.thecoinguild.com 
Trading Review Checking in on Shares of Polydex Pharmaceuticals Ltd.
news
The Coin GuildFull coverage
over three months ago at http://www.thecoinguild.com 
Trading Update Investors Focusing on Shares of FBL Financial Group, Inc. as Company Makes Headlines ...
news
The Coin GuildFull coverage
over a year ago at http://www.ptcommunity.com 
Nexstim Plc Appoints Steve Beller as Vice President and General Manager, North ...
news
PT Community - Dec 1, 2017 Nexstim Plc , a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, announces the appointment ...

Latest Stories

Recently Published Stories

Compare Polydex Pharmaceuticals

Compare Polydex Pharmaceuticals To Peers

Cash Flow from Operations

Cash Flow from Operations Comparative Analysis

  Cash Flow from Operations 
      Polydex Pharmaceuticals Comparables 
Polydex Pharmaceuticals is currently under evaluation in cash flow from operations category among related companies. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investor or analyst to check on the quality of a company earnings.
Additionally take a look at Polydex Pharmaceuticals Hype Analysis, Polydex Pharmaceuticals Correlation and Polydex Pharmaceuticals Performance. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Search macroaxis.com